desipramine has been researched along with Somatoform Disorders in 4 studies
Desipramine: A tricyclic dibenzazepine compound that potentiates neurotransmission. Desipramine selectively blocks reuptake of norepinephrine from the neural synapse, and also appears to impair serotonin transport. This compound also possesses minor anticholinergic activity, through its affinity to muscarinic receptors.
desipramine : A dibenzoazepine consisting of 10,11-dihydro-5H-dibenzo[b,f]azepine substituted on nitrogen with a 3-(methylamino)propyl group.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Clomipramine was superior to desipramine in the acute treatment of body dysmorphic disorder symptoms as measured by assessment of patients' obsessive preoccupation with perceived body defects, repetitive behaviors in response to this preoccupation, and global ratings of symptom severity." | 2.69 | Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness. ( Allen, A; Aronowitz, B; Hollander, E; Kwon, J; Schmeidler, J; Simeon, D; Wong, C, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ipser, JC | 1 |
| Sander, C | 1 |
| Stein, DJ | 1 |
| Frances, A | 1 |
| Petti, TA | 1 |
| Hollander, E | 1 |
| Allen, A | 1 |
| Kwon, J | 1 |
| Aronowitz, B | 1 |
| Schmeidler, J | 1 |
| Wong, C | 1 |
| Simeon, D | 1 |
| Phillips, KA | 1 |
| Rasmussen, SA | 1 |
| Price, LH | 1 |
1 review available for desipramine and Somatoform Disorders
| Article | Year |
|---|---|
Pharmacotherapy and psychotherapy for body dysmorphic disorder.
Topics: Adrenergic Uptake Inhibitors; Body Image; Clomipramine; Cognitive Behavioral Therapy; Desipramine; F | 2009 |
1 trial available for desipramine and Somatoform Disorders
| Article | Year |
|---|---|
Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness.
Topics: Adrenergic Uptake Inhibitors; Adult; Clomipramine; Comorbidity; Cross-Over Studies; Delusions; Desip | 1999 |
2 other studies available for desipramine and Somatoform Disorders
| Article | Year |
|---|---|
Boy with seriously ill mother manifests somatic complaints, withdrawal, disabling fears.
Topics: Adjustment Disorders; Child; Child Reactive Disorders; Combined Modality Therapy; Desipramine; Famil | 1984 |
Treating imagined ugliness.
Topics: Adrenergic Uptake Inhibitors; Clomipramine; Desipramine; Double-Blind Method; Female; Humans; Male; | 1999 |